|
|
Flinders Academic Commons >
Research Publications >
07 - Biomedical and Clinical Research >
1112 - Oncology and Carcinogenesis >
Please use this identifier to cite or link to this item:
http://hdl.handle.net/2328/11131
|
| Title: | K-ras mutations and benefit from Cetuximab in
advanced colorectal cancer |
| Authors: | Au, Heather-Jane Karapetis, Christos Stelios Khambata-Ford, Shirin Jonker, Derek Tu, Dongsheng Tebbutt, Niall C. Price, Timothy J Simes, R. John Chalchal, Haji Shapiro, Jeremy D. Langer, Christiane Moore, Malcolm J. Zalcberg, John R. Robitaille, Sonia Shepherd, Lois O'Callaghan, Chris J |
| Issue Date: | 2008 |
| Citation: | Karapetis, C.S., Khambata-Ford, S.,
Jonker, D., O'Callaghan, C.j., Tu, D., Tebbutt, N.C., Simes, R.J., Chalchal, H.,
Shapiro, J.D., Robitaille, S., et al., 2008. K-ras mutations and benefit from Cetuximab
in advanced colorectal cancer. New England Journal of Medicine, 359(17),
1757-1765. |
| URI: | http://hdl.handle.net/2328/11131 |
| ISSN: | 0028-4793 |
| Appears in Collections: | 1112 - Oncology and Carcinogenesis
|
Files in This Item:
There are no files associated with this item.
|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
|